Old Therapy, New Questions: Rethinking Phlebotomy in a Pharmacologic Landscape [PDF]
PharmaceuticalsTherapeutic phlebotomy remains a key intervention in the management of erythrocytosis and iron overload disorders, particularly polycythemia vera (PV) and hereditary hemochromatosis.
Andrea Duminuco +12 more
doaj +2 more sources
Effect of therapeutic phlebotomy on plasma volume in polycythemia patients
Global Journal of Transfusion Medicine, 2018 Background: Therapeutic phlebotomy (TP) helps in reducing the red cell mass thereby whole blood viscosity to improve tissue perfusion and oxygen delivery in polycythemia patients.
Mohandoss Murugesan +2 more
doaj +2 more sources
Periodic Therapeutic Phlebotomy Mitigates Systemic Aging Phenotypes by Promoting Bone Marrow Function. [PDF]
Aging CellABSTRACT Aging is the primary risk factor for numerous chronic diseases, making the identification of safe and effective anti‐aging strategies a critical focus in biomedical research. Heterochronic parabiosis by blood exchange shows that the exchange interaction between young and old plasma can exert anti‐aging effects through ...
Cai JR +7 more
europepmc +3 more sources
Role of therapeutic apheresis and phlebotomy techniques in anaesthesia and critical care
Indian Journal of Anaesthesia, 2014 Therapeutic transfusion techniques such as apheresis and phlebotomy are frequently used in intensive care units. Use of the apheresis technique for the treatment of various diseases in critically ill patients is growing day by day. There are increasing evidences for using apheresis as a primary therapy or as an adjunct to other therapies for various ...
Neeta Bose, Hitendra Kanzariya
doaj +3 more sources
Nine treatments of 1000 mL therapeutic phlebotomy in a subject with polycythemia: A case report
Physiological ReportsLarge‐volume therapeutic phlebotomy is the mainstay of hemochromatosis treatment and offers an opportunity to investigate the hemodynamic changes during acute hypovolemia. An otherwise healthy 64‐year‐old male with hemochromatosis participated.
William J. Morton +5 more
doaj +3 more sources
Identification and Treatment of Intravascular Hypervolemia and Polycythemia in Patients With Heart Failure: Role of Therapeutic Phlebotomy. [PDF]
JACC Case RepIntravascular hypervolemia with polycythemia is a blood volume phenotype in patients with heart failure that portends additional risks including thrombotic events. This paper presents 4 patients with heart failure with this blood volume phenotype and focuses on its identification and the role of therapeutic phlebotomy including patient selection and ...
Al Abbas M, Sagaram S, Silver MA.
europepmc +3 more sources
PB2505: THERAPEUTIC PHLEBOTOMY INSTANTLY AFFECTS BLOOD PARAMETERS AND VISCOCITY IN SICKLE CELL DISEASE PATIENTS [PDF]
HemaSphere, 2023 Amna Jebali +5 more
doaj +2 more sources
Advances in polycythemia vera treatment with targeted therapies and clinical trials [PDF]
Discover OncologyPolycythemia vera (PV) is a chronic myeloproliferative disorder characterized by excessive red blood cell production, leading to a heightened risk of thrombosis, hemorrhage, and progression to myelofibrosis. While traditional therapies such as phlebotomy
Doaa Hassanien +7 more
doaj +2 more sources
Hemoglobin suresnes combined with α0-thalassemia: Diagnostic challenges and insights from trio-based whole exome sequencing [PDF]
Annals of HematologyHemoglobin Suresnes (Hb Suresnes) is a rare hemoglobin variant caused by a substitution of arginine to histidine at position 141 (p.Arg142His) in the COOH terminus of the α-globin chain. This structural change alters the oxygen affinity of hemoglobin and
Hung-Lin Liu, Wan-Ting Huang
doaj +2 more sources